View In Browser

Infectious Diseases Society of St. Louis

hosts a CME-Accredited VIRTUAL Meeting

 COVID-19 Panel:
Ask the Experts

Moderated by
F. Matthew Kuhlmann, MD
Assistant Professor of Medicine
Washington University
School of Medicine

President, ID Society of St. Louis

Join us to discuss local effort, treatment & vaccines.

Local Response & Challenges
Clay Dunagan, MD, MS
Professor of Medicine
Chief Clinical Officer, BJC HealthCare
Washington University School of Medicine, St. Louis, MO 
​​​​​St. Louis Metropolitan Pandemic Task Force​​​​

The Why and Wherefore of
SARS CoV-2 Booster 
Sharon Frey, MD
Professor Medicine
Clinical Director, Saint Louis University 
Center for Vaccine Development, St. Louis, MO

Treatment Options for COVID-19
Jane O'Halloran, MD, PhD
Assistant Professor of Medicine
Associate Director of Virology, Infectious Diseases Clinical Research Unit (ID-CRU), Washington University School of Medicine, St. Louis MO 

Immunology of Infection & Vaccines
Rachel M. Presti, MD, PhD
Associate Professor of Medicine
Clinical Director, ID Clinical Research Unit (ID-CRU)
Washington University School of Medicine
St. Louis, MO


October 14, 2021

Meet our exhibitors by ZOOM in the Exhibit Hall

Meeting zoom link will be emailed to registrants. 

scroll to "Infectious Diseases
Society and Event Registration"

  • No Fee for fellows-in-training or 2021 ID Society of St. Louis members (including new online memberships)
    Not sure you are a member? Call (314) 454-8275 or email.
  • $60 new/renew membership
  • $75 non-clinician registration

October 11, 2021

This course is designed for physicians whose practice includes infectious 
diseases. Physician assistants, nurse practitioners, registered nurses and 
pharmacists are also welcome to participate. 

Upon completion of this educational activity, participants should be able to:

  • describe the St. Louis Regional COVID response and understand its impact on regional case rates, mortality rates, and health system capacity, 

  • identify current and future treatment options for mild and moderate/severe

  • explain antibody decay post SARS-CoV-2 vaccine prime,

  • summarize current recommendations for SARS-CoV-2 vaccine booster, and 

  • ​​​​discuss translational research finding regarding immunity to SARS-CoV-2 & vaccination, and future research opportunities. 

CONTACT Email Susan Wightman if you have any questions. 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Missouri State Medical Association (MSMA) through the joint providership of the St. Louis STD/HIV Prevention Training Center and ID Society of St. Louis.  The St. Louis STD/HIV Prevention Training Center is accredited by the MSMA to provide continuing medical education for physicians.

The St. Louis STI/HIV Prevention Training Center is accredited by the MSMA to provide continuing medical education for physicians. The St. Louis STI/HIV Prevention Training Center designates this educational activity for 1.5 Category 1 credits toward the AMA Physician’s AwardTM.